Gsa Capital Partners LLP Biogen Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Biogen Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 4,407 shares of BIIB stock, worth $696,350. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,407

Previous 3,048 44.59%

Holding current value

$696,350

Previous $707,000 20.79%

% of portfolio

0.06%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$189.07 - $236.8 $256,946 - $321,811	1,359 Added 44.59%	4,407 $854,000
Q2 2024 Aug 15, 2024	SELL	$190.52 - $236.72 $14,289 - $17,754	-75 Reduced 2.4%	3,048 $707,000
Q1 2024 May 03, 2024	BUY	$212.02 - $267.71 $350,257 - $442,256	1,652 Added 112.3%	3,123 $673,000
Q4 2023 Feb 16, 2024	BUY	$222.59 - $267.94 $327,429 - $394,139	1,471 New	1,471 $380,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $1.34 Million - $1.63 Million	5,316 New	5,316 $1.47 Million
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $145,155 - $172,617	-774 Reduced 19.8%	3,136 $640,000
Q1 2022 May 11, 2022	BUY	$193.77 - $244.14 $757,640 - $954,587	3,910 New	3,910 $823,000
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $751,704 - $953,547	-2,796 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $533,645 - $737,369	-2,425 Reduced 46.45%	2,796 $830,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $1.87 Million - $2.09 Million	-8,579 Reduced 62.17%	5,221 $1.22 Million
Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $2.74 Million - $3.02 Million	-12,505 Reduced 47.54%	13,800 $3.23 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $4.62 Million - $7.23 Million	21,325 Added 428.21%	26,305 $6.22 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $38,154 - $48,326	137 Added 2.83%	4,980 $1.5 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.55 Million - $2.03 Million	-5,297 Reduced 52.24%	4,843 $1.71 Million
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $1.07 Million - $1.27 Million	4,138 Added 68.94%	10,140 $2.94 Million
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $2.12 Million - $2.99 Million	-8,131 Reduced 57.53%	6,002 $1.64 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $3.64 Million - $4.08 Million	11,845 Added 517.7%	14,133 $4.5 Million
Q3 2017 Nov 20, 2017	BUY	$281.15 - $329.69 $643,271 - $754,330	2,288	2,288 $716,000

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Biogen Inc. Transaction History